retatrutide type 2 diabetes phase 2 trial hba1c π©Ί in diabetes: TRANSCEND-T2D-1 3 results β β2.0% + weight β16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. ππ Ref: Lilly Clinical trials of subcutaneous tirzepatide,
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 1 - Aug 6













![KLOW [80MG] β Legionary Peptides](https://legionarypeptides.com/wp-content/uploads/2026/02/klow80_peptide-936x1024.jpg)














